The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hepatitis B Vaccines Market Research Report 2025
Synopsis
The global Hepatitis B Vaccines market was valued at US$ 1269 million in 2023 and is anticipated to reach US$ 1985 million by 2030, witnessing a CAGR of 6.45% during the forecast period 2024-2030.
North American market for Hepatitis B Vaccines is estimated to increase from $ 568 million in 2023 to reach $ 964 million by 2030, at a CAGR of 7.48% during the forecast period of 2024 through 2030.
Asia-Pacific market for Hepatitis B Vaccines is estimated to increase from $ 397.5 million in 2023 to reach $ 554.68 million by 2030, at a CAGR of 4.92% during the forecast period of 2024 through 2030.
The major global manufacturers of Hepatitis B Vaccines include GSK, NCPC, Merck, Bio Kangtai, Dynavax, AIM Vaccine, KM Biologics, LG Life Sciences, Serum Institute, etc. In 2023, the world's top five vendors accounted for approximately 79.66% of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Vaccines.
The Hepatitis B Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis B Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
NCPC
Merck
Bio Kangtai
Dynavax
AIM Vaccine
KM Biologics
LG Life Sciences
Serum Institute
Segment by Type
Yeast Derived
CHO Derived
Segment by Application
Children
Adult
Consumption by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Europe
Germany
France
U.K.
Italy
Benelux
Rest of Europe
South America
Brazil
Other
Middle East & Africa
Middle East
Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatitis B Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Hepatitis B Vaccines market was valued at US$ 1269 million in 2023 and is anticipated to reach US$ 1985 million by 2030, witnessing a CAGR of 6.45% during the forecast period 2024-2030.
North American market for Hepatitis B Vaccines is estimated to increase from $ 568 million in 2023 to reach $ 964 million by 2030, at a CAGR of 7.48% during the forecast period of 2024 through 2030.
Asia-Pacific market for Hepatitis B Vaccines is estimated to increase from $ 397.5 million in 2023 to reach $ 554.68 million by 2030, at a CAGR of 4.92% during the forecast period of 2024 through 2030.
The major global manufacturers of Hepatitis B Vaccines include GSK, NCPC, Merck, Bio Kangtai, Dynavax, AIM Vaccine, KM Biologics, LG Life Sciences, Serum Institute, etc. In 2023, the world's top five vendors accounted for approximately 79.66% of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Vaccines.
The Hepatitis B Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis B Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
NCPC
Merck
Bio Kangtai
Dynavax
AIM Vaccine
KM Biologics
LG Life Sciences
Serum Institute
Segment by Type
Yeast Derived
CHO Derived
Segment by Application
Children
Adult
Consumption by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Europe
Germany
France
U.K.
Italy
Benelux
Rest of Europe
South America
Brazil
Other
Middle East & Africa
Middle East
Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatitis B Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hepatitis B Vaccines Market Overview 1
1.1 Product Definition 1
1.2 Hepatitis B Vaccines by Type 1
1.2.1 Global Hepatitis B Vaccines Market Value Comparison by Type (2024-2030) 2
1.2.2 Yeast Derived 3
1.2.3 CHO Derived 4
1.3 Hepatitis B Vaccines by Application 5
1.3.1 Global Hepatitis B Vaccines Market Value by Application (2024-2030) 5
1.3.2 Children 7
1.3.3 Adult 8
1.4 Global Hepatitis B Vaccines Market Size Estimates and Forecasts 9
1.4.1 Global Hepatitis B Vaccines Revenue 2019-2030 9
1.4.2 Global Hepatitis B Vaccines Sales 2019-2030 10
1.4.3 Global Hepatitis B Vaccines Market Average Price (2019-2030) 11
1.5 Assumptions and Limitations 11
2 Hepatitis B Vaccines Market Competition by Manufacturers 14
2.1 Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2019-2024) 14
2.2 Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2019-2024) 16
2.3 Global Hepatitis B Vaccines Average Price by Manufacturers (2019-2024) 18
2.4 Global Key Players of Hepatitis B Vaccines, Industry Ranking, 2022 VS 2023 VS 2024 19
2.5 Global Key Manufacturers of Hepatitis B Vaccines, Manufacturing Sites & Headquarters 19
2.6 Global Key Manufacturers of Hepatitis B Vaccines, Product Type & Application 20
2.7 Global Key Manufacturers of Hepatitis B Vaccines, Date of Enter into This Industry 20
2.8 Global Hepatitis B Vaccines Market Competitive Situation and Trends 21
2.8.1 Global Hepatitis B Vaccines Market Concentration Rate 21
2.8.2 The Global 5 and 9 Largest Hepatitis B Vaccines Players Market Share by Revenue 22
2.8.3 Global Hepatitis B Vaccines Market by Company Type (Tier 1, Tier 2, and Tier 3) 23
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans 24
3 Global Hepatitis B Vaccines Market Scenario by Region 25
3.1 Global Hepatitis B Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030 25
3.2 Global Hepatitis B Vaccines Sales by Region: 2019-2030 26
3.2.1 Global Hepatitis B Vaccines Sales by Region: 2019-2024 26
3.2.2 Global Hepatitis B Vaccines Sales by Region: 2025-2030 27
3.3 Global Hepatitis B Vaccines Revenue by Region: 2019-2030 28
3.3.1 Global Hepatitis B Vaccines Revenue by Region: 2019-2024 28
3.3.2 Global Hepatitis B Vaccines Revenue by Region: 2025-2030 28
3.4 North America Hepatitis B Vaccines Market Facts & Figures by Country 29
3.4.1 North America Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030 29
3.4.2 North America Hepatitis B Vaccines Sales by Country (2019-2030) 29
3.4.3 North America Hepatitis B Vaccines Revenue by Country (2019-2030) 30
3.4.4 U.S. 32
3.4.5 Canada 32
3.4.6 Mexico 33
3.5 Europe Hepatitis B Vaccines Market Facts & Figures by Country 33
3.5.1 Europe Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030 33
3.5.2 Europe Hepatitis B Vaccines Sales by Country (2019-2030) 34
3.5.3 Europe Hepatitis B Vaccines Revenue by Country (2019-2030) 35
3.5.4 Germany 37
3.5.5 France 37
3.5.6 U.K. 38
3.5.7 Italy 38
3.5.8 Benelux 39
3.6 Asia Pacific Hepatitis B Vaccines Market Facts & Figures by Region 39
3.6.1 Asia Pacific Hepatitis B Vaccines Market Size by Region: 2019 VS 2023 VS 2030 39
3.6.2 Asia Pacific Hepatitis B Vaccines Sales by Region (2019-2030) 40
3.6.3 Asia Pacific Hepatitis B Vaccines Revenue by Region (2019-2030) 41
3.6.4 China 42
3.6.5 Japan 43
3.6.6 South Korea 43
3.6.7 India 44
3.6.8 Southeast Asia 44
3.7 South America Hepatitis B Vaccines Market Facts & Figures by Country 45
3.7.1 South America Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030 45
3.7.2 South America Hepatitis B Vaccines Sales by Country (2019-2030) 45
3.7.3 South America Hepatitis B Vaccines Revenue by Country 46
3.7.4 Brazil 47
3.8 Middle East and Africa Hepatitis B Vaccines Market Facts & Figures by Country 47
3.8.1 Middle East and Africa Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030 47
3.8.2 Middle East and Africa Hepatitis B Vaccines Sales by Country (2019-2030) 48
3.8.3 Middle East and Africa Hepatitis B Vaccines Revenue by Country 49
3.8.4 Middle East 50
3.8.5 Africa 50
4 Segment by Type 51
4.1 Global Hepatitis B Vaccines Sales by Type (2019-2030) 51
4.1.1 Global Hepatitis B Vaccines Sales by Type (2019-2024) 51
4.1.2 Global Hepatitis B Vaccines Sales by Type (2025-2030) 51
4.1.3 Global Hepatitis B Vaccines Sales Market Share by Type (2019-2030) 51
4.2 Global Hepatitis B Vaccines Revenue by Type (2019-2030) 52
4.2.1 Global Hepatitis B Vaccines Revenue by Type (2019-2024) 52
4.2.2 Global Hepatitis B Vaccines Revenue by Type (2025-2030) 53
4.2.3 Global Hepatitis B Vaccines Revenue Market Share by Type (2019-2030) 53
4.3 Global Hepatitis B Vaccines Price by Type (2019-2030) 54
5 Segment by Application 56
5.1 Global Hepatitis B Vaccines Sales by Application (2019-2030) 56
5.1.1 Global Hepatitis B Vaccines Sales by Application (2019-2024) 56
5.1.2 Global Hepatitis B Vaccines Sales by Application (2025-2030) 56
5.1.3 Global Hepatitis B Vaccines Sales Market Share by Application (2019-2030) 56
5.2 Global Hepatitis B Vaccines Revenue by Application (2019-2030) 57
5.2.1 Global Hepatitis B Vaccines Revenue by Application (2019-2024) 57
5.2.2 Global Hepatitis B Vaccines Revenue by Application (2025-2030) 58
5.2.3 Global Hepatitis B Vaccines Revenue Market Share by Application (2019-2030) 58
5.3 Global Hepatitis B Vaccines Price by Application (2019-2030) 59
6 Key Companies Profiled 61
6.1 GSK 61
6.1.1 GSK Company Information 61
6.1.2 GSK Description and Business Overview 61
6.1.3 GSK Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024) 62
6.1.4 GSK Hepatitis B Vaccines Product Portfolio 62
6.2 NCPC 63
6.2.1 NCPC Company Information 63
6.2.2 NCPC Description and Business Overview 64
6.2.3 NCPC Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024) 64
6.2.4 NCPC Hepatitis B Vaccines Product Portfolio 64
6.3 Merck 65
6.3.1 Merck Company Information 65
6.3.2 Merck Description and Business Overview 66
6.3.3 Merck Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024) 66
6.3.4 Merck Hepatitis B Vaccines Product Portfolio 66
6.4 Bio Kangtai 67
6.4.1 Bio Kangtai Company Information 67
6.4.2 Bio Kangtai Description and Business Overview 68
6.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024) 68
6.4.4 Bio Kangtai Hepatitis B Vaccines Product Portfolio 68
6.5 Dynavax 70
6.5.1 Dynavax Company Information 70
6.5.2 Dynavax Description and Business Overview 70
6.5.3 Dynavax Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024) 71
6.5.4 Dynavax Hepatitis B Vaccines Product Portfolio 71
6.5.5 Dynavax Recent Developments/Updates 72
6.6 AIM Vaccine 73
6.6.1 AIM Vaccine Company Information 73
6.6.2 AIM Vaccine Description and Business Overview 73
6.6.3 AIM Vaccine Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024) 74
6.6.4 AIM Vaccine Hepatitis B Vaccines Product Portfolio 74
6.7 KM Biologics 75
6.7.1 KM Biologics Company Information 75
6.7.2 KM Biologics Description and Business Overview 76
6.7.3 KM Biologics Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024) 76
6.7.4 KM Biologics Hepatitis B Vaccines Product Portfolio 76
6.8 LG Life Sciences 77
6.8.1 LG Life Sciences Company Information 78
6.8.2 LG Life Sciences Description and Business Overview 78
6.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024) 78
6.8.4 LG Life Sciences Hepatitis B Vaccines Product Portfolio 79
6.8.5 LG Life Sciences Recent Developments/Updates 80
6.9 Serum Institute 80
6.9.1 Serum Institute Company Information 81
6.9.2 Serum Institute Description and Business Overview 81
6.9.3 Serum Institute Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024) 82
6.9.4 Serum Institute Hepatitis B Vaccines Product Portfolio 82
7 Industry Chain and Sales Channels Analysis 83
7.1 Hepatitis B Vaccines Industry Chain Analysis 83
7.2 Hepatitis B Vaccines Key Raw Materials 84
7.2.1 Key Raw Materials 84
7.2.2 Raw Materials Key Suppliers 84
7.3 Hepatitis B Vaccines Production Mode & Process 86
7.4 Hepatitis B Vaccines Sales and Marketing 87
7.4.1 Hepatitis B Vaccines Sales Channels 87
7.4.2 Hepatitis B Vaccines Distributors 89
7.5 Hepatitis B Vaccines Customers 90
8 Hepatitis B Vaccines Market Dynamics 93
8.1 Hepatitis B Vaccines Industry Trends 93
8.2 Hepatitis B Vaccines Market Drivers 94
8.3 Hepatitis B Vaccines Market Challenges 94
8.4 Hepatitis B Vaccines Market Restraints 95
9 Research Findings and Conclusion 97
10 Methodology and Data Source 99
10.1 Methodology/Research Approach 99
10.1.1 Research Programs/Design 99
10.1.2 Market Size Estimation 100
10.1.3 Market Breakdown and Data Triangulation 101
10.2 Data Source 102
10.2.1 Secondary Sources 102
10.2.2 Primary Sources 103
10.3 Author List 105
10.4 Disclaimer 106
List of TablesTable 1. Global Hepatitis B Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million) 2
Table 2. Major Manufacturers of Yeast Derived 4
Table 3. Major Manufacturers of CHO Derived 5
Table 4. Global Hepatitis B Vaccines Market Value by Application (2024-2030) & (US$ Million) 5
Table 5. Global Hepatitis B Vaccines Market Competitive Situation by Manufacturers in 2023 14
Table 6. Global Hepatitis B Vaccines Sales (M Doses) of Key Manufacturers (2019-2024) 15
Table 7. Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2019-2024) 15
Table 8. Global Hepatitis B Vaccines Revenue (US$ Million) by Manufacturers (2019-2024) 16
Table 9. Global Hepatitis B Vaccines Revenue Share by Manufacturers (2019-2024) 17
Table 10. Global Market Hepatitis B Vaccines Average Price (USD/Doses) of Key Manufacturers (2019-2024) 18
Table 11. Global Key Players of Hepatitis B Vaccines, Industry Ranking, 2022 VS 2023 VS 2024 19
Table 12. Global Key Manufacturers of Hepatitis B Vaccines, Manufacturing Sites & Headquarters 19
Table 13. Global Key Manufacturers of Hepatitis B Vaccines, Product Type & Application 20
Table 14. Global Key Manufacturers of Hepatitis B Vaccines, Date of Enter into This Industry 20
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) 21
Table 16. Global Hepatitis B Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccines as of 2023) 23
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans 24
Table 18. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030 25
Table 19. Global Hepatitis B Vaccines Sales by Region (2019-2024) & (M Doses) 26
Table 20. Global Hepatitis B Vaccines Sales Market Share by Region (2019-2024) 27
Table 21. Global Hepatitis B Vaccines Sales by Region (2025-2030) & (M Doses) 27
Table 22. Global Hepatitis B Vaccines Sales Market Share by Region (2025-2030) 27
Table 23. Global Hepatitis B Vaccines Revenue by Region (2019-2024) & (US$ Million) 28
Table 24. Global Hepatitis B Vaccines Revenue Market Share by Region (2019-2024) 28
Table 25. Global Hepatitis B Vaccines Revenue by Region (2025-2030) & (US$ Million) 28
Table 26. Global Hepatitis B Vaccines Revenue Market Share by Region (2025-2030) 29
Table 27. North America Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million) 29
Table 28. North America Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses) 29
Table 29. North America Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses) 30
Table 30. North America Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million) 30
Table 31. North America Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million) 31
Table 32. Europe Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million) 33
Table 33. Europe Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses) 34
Table 34. Europe Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses) 34
Table 35. Europe Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million) 35
Table 36. Europe Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million) 35
Table 37. Asia Pacific Hepatitis B Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million) 39
Table 38. Asia Pacific Hepatitis B Vaccines Sales by Region (2019-2024) & (M Doses) 40
Table 39. Asia Pacific Hepatitis B Vaccines Sales by Region (2025-2030) & (M Doses) 40
Table 40. Asia Pacific Hepatitis B Vaccines Revenue by Region (2019-2024) & (US$ Million) 41
Table 41. Asia Pacific Hepatitis B Vaccines Revenue by Region (2025-2030) & (US$ Million) 41
Table 42. South America Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million) 45
Table 43. South America Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses) 45
Table 44. South America Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses) 45
Table 45. South America Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million) 46
Table 46. South America Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million) 46
Table 47. Middle East and Africa Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million) 47
Table 48. Middle East and Africa Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses) 48
Table 49. Middle East and Africa Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses) 48
Table 50. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million) 49
Table 51. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million) 49
Table 52. Global Hepatitis B Vaccines Sales (M Doses) by Type (2019-2024) 51
Table 53. Global Hepatitis B Vaccines Sales (M Doses) by Type (2025-2030) 51
Table 54. Global Hepatitis B Vaccines Sales Market Share by Type (2019-2024) 51
Table 55. Global Hepatitis B Vaccines Sales Market Share by Type (2025-2030) 52
Table 56. Global Hepatitis B Vaccines Revenue (US$ Million) by Type (2019-2024) 52
Table 57. Global Hepatitis B Vaccines Revenue (US$ Million) by Type (2025-2030) 53
Table 58. Global Hepatitis B Vaccines Revenue Market Share by Type (2019-2024) 53
Table 59. Global Hepatitis B Vaccines Revenue Market Share by Type (2025-2030) 53
Table 60. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2019-2024) 54
Table 61. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2025-2030) 54
Table 62. Global Hepatitis B Vaccines Sales (M Doses) by Application (2019-2024) 56
Table 63. Global Hepatitis B Vaccines Sales (M Doses) by Application (2025-2030) 56
Table 64. Global Hepatitis B Vaccines Sales Market Share by Application (2019-2024) 56
Table 65. Global Hepatitis B Vaccines Sales Market Share by Application (2025-2030) 57
Table 66. Global Hepatitis B Vaccines Revenue (US$ Million) by Application (2019-2024) 57
Table 67. Global Hepatitis B Vaccines Revenue (US$ Million) by Application (2025-2030) 58
Table 68. Global Hepatitis B Vaccines Revenue Market Share by Application (2019-2024) 58
Table 69. Global Hepatitis B Vaccines Revenue Market Share by Application (2025-2030) 58
Table 70. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2019-2024) 59
Table 71. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2025-2030) 59
Table 72. GSK Company Information 61
Table 73. GSK Description and Business Overview 61
Table 74. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024) 62
Table 75. GSK Hepatitis B Vaccines Product 62
Table 76. NCPC Company Information 63
Table 77. NCPC Description and Business Overview 64
Table 78. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024) 64
Table 79. NCPC Hepatitis B Vaccines Product 64
Table 80. Merck Company Information 65
Table 81. Merck Description and Business Overview 66
Table 82. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024) 66
Table 83. Merck Hepatitis B Vaccines Product 66
Table 84. Bio Kangtai Company Information 67
Table 85. Bio Kangtai Description and Business Overview 68
Table 86. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024) 68
Table 87. Bio Kangtai Hepatitis B Vaccines Product 68
Table 88. Dynavax Company Information 70
Table 89. Dynavax Description and Business Overview 70
Table 90. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024) 71
Table 91. Dynavax Hepatitis B Vaccines Product 71
Table 92. Dynavax Recent Developments/Updates 72
Table 93. AIM Vaccine Company Information 73
Table 94. AIM Vaccine Description and Business Overview 73
Table 95. AIM Vaccine Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024) 74
Table 96. AIM Vaccine Hepatitis B Vaccines Product 74
Table 97. KM Biologics Company Information 75
Table 98. KM Biologics Description and Business Overview 76
Table 99. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024) 76
Table 100. KM Biologics Hepatitis B Vaccines Product 76
Table 101. LG Life Sciences Company Information 78
Table 102. LG Life Sciences Description and Business Overview 78
Table 103. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024) 78
Table 104. LG Life Sciences Hepatitis B Vaccines Product 79
Table 105. LG Life Sciences Recent Developments/Updates 80
Table 106. Serum Institute Company Information 81
Table 107. Serum Institute Description and Business Overview 81
Table 108. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024) 82
Table 109. Serum Institute Hepatitis B Vaccines Product 82
Table 110. Key Raw Materials Lists 84
Table 111. Raw Materials Key Suppliers Lists 84
Table 112. Hepatitis B Vaccines Distributors List 89
Table 113. Hepatitis B Vaccines Customers List 90
Table 114. Hepatitis B Vaccines Market Trends 93
Table 115. Hepatitis B Vaccines Market Drivers 94
Table 116. Hepatitis B Vaccines Market Challenges 94
Table 117. Hepatitis B Vaccines Market Restraints 95
Table 118. Research Programs/Design for This Report 99
Table 119. Key Data Information from Secondary Sources 103
Table 120. Key Data Information from Primary Sources 104
Table 121. Authors List of This Report 105
List of Figures
Figure 1. Product Picture of Hepatitis B Vaccines 1
Figure 2. Global Hepatitis B Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million) 2
Figure 3. Global Hepatitis B Vaccines Market Share by Type: 2023 3
Figure 4. Global Hepatitis B Vaccines Market Share by Type: 2030 3
Figure 5. Yeast Derived Product Picture 4
Figure 6. CHO Derived Product Picture 5
Figure 7. Global Hepatitis B Vaccines Market Value by Application (2024-2030) & (US$ Million) 6
Figure 8. Global Hepatitis B Vaccines Market Share by Application: 2023 7
Figure 9. Global Hepatitis B Vaccines Market Share by Application: 2030 7
Figure 10. Children 8
Figure 11. Adult 8
Figure 12. Global Hepatitis B Vaccines Revenue, (US$ Million), 2019 VS 2024 VS 2030 9
Figure 13. Global Hepatitis B Vaccines Market Size (2019-2030) & (US$ Million) 10
Figure 14. Global Hepatitis B Vaccines Sales (2019-2030) & (M Doses) 10
Figure 15. Global Hepatitis B Vaccines Average Price (USD/Doses) & (2019-2030) 11
Figure 16. Hepatitis B Vaccines Report Years Considered 12
Figure 17. Hepatitis B Vaccines Sales Share by Manufacturers in 2023 16
Figure 18. Global Hepatitis B Vaccines Revenue Share by Manufacturers in 2023 18
Figure 19. Global 5 Largest Hepatitis B Vaccines Players: Market Share by Revenue in Hepatitis B Vaccines in 2023 22
Figure 20. Global 9 Largest Hepatitis B Vaccines Players: Market Share by Revenue in Hepatitis B Vaccines in 2023 23
Figure 21. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2019-2030 26
Figure 22. North America Hepatitis B Vaccines Sales Market Share by Country (2019-2030) 30
Figure 23. North America Hepatitis B Vaccines Revenue Market Share by Country (2019-2030) 31
Figure 24. U.S. Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 32
Figure 25. Canada Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 32
Figure 26. Mexico Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 33
Figure 27. Europe Hepatitis B Vaccines Sales Market Share by Country (2019-2030) 35
Figure 28. Europe Hepatitis B Vaccines Revenue Market Share by Country (2019-2030) 36
Figure 29. Germany Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 37
Figure 30. France Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 37
Figure 31. U.K. Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 38
Figure 32. Italy Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 38
Figure 33. Benelux Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 39
Figure 34. Asia Pacific Hepatitis B Vaccines Sales Market Share by Region (2019-2030) 41
Figure 35. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Region (2019-2030) 42
Figure 36. China Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 42
Figure 37. Japan Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 43
Figure 38. South Korea Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 43
Figure 39. India Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 44
Figure 40. Southeast Asia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 44
Figure 41. South America Hepatitis B Vaccines Sales Market Share by Country (2019-2030) 46
Figure 42. Brazil Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 47
Figure 43. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Country (2019-2030) 48
Figure 44. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Country (2019-2030) 49
Figure 45. Middle East Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 50
Figure 46. Africa Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million) 50
Figure 47. Global Sales Market Share of Hepatitis B Vaccines by Type (2019-2030) 52
Figure 48. Global Revenue Market Share of Hepatitis B Vaccines by Type (2019-2030) 54
Figure 49. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2019-2030) 55
Figure 50. Global Sales Market Share of Hepatitis B Vaccines by Application (2019-2030) 57
Figure 51. Global Revenue Market Share of Hepatitis B Vaccines by Application (2019-2030) 59
Figure 52. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2019-2030) 60
Figure 53. Hepatitis B Vaccines Value Chain 83
Figure 54. Hepatitis B Vaccines Production Process (Yeast Derived) 86
Figure 55. Channels of Distribution 88
Figure 56. Bottom-up and Top-down Approaches for This Report 101
Figure 57. Data Triangulation 102
Figure 58. Key Executives Interviewed 104
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
